Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
复制标题
单月桂酸甘油酯抑制炭疽杆菌毒力因子的产生。
DOI:
10.1128/aac.49.4.1302-1305.2005
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Schlievert,PatrickM
中科院分区:
文献类型:
--
作者:
Vetter,SaraM;Schlievert,PatrickM
Anthrax, caused byBacillus anthracis, has been brought to the public's attention because of the 2001 bioterrorism attacks. However, anthrax is a disease that poses agricultural threats in the United States as well as human populations in Europe, China, Africa, and Australia. Glycerol monolaurate (GML) is a compound that has been shown to inhibit exotoxin production byStaphylococcus aureusand other gram-positive bacteria. Here, we study the effects of GML on growth and toxin production inB. anthracis. The Sterne strain ofB. anthraciswas grown to post-exponential phase with 0-, 10-, 15-, or 20-μg/ml concentrations of GML and then assayed quantitatively for protective antigen (PA) and lethal factor (LF). After 8 h, GML at concentrations greater than 20 μg/ml was bacteriostatic to growth of the organism. However, a 10-μg/ml concentration of GML was not growth inhibitory, but amounts of PA and LF made were greatly reduced. This effect was not global for all proteins when total secreted protein from culture fluids was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Through quantitative reverse transcription-PCR assays, this toxin-inhibitory effect was shown to occur at the transcriptional level, since amounts of mRNA forpagA(PA),lef(LF), andcya(edema factor) were reduced. Surprisingly, mRNA levels ofatxA, a regulator of exotoxin gene expression, rose in the presence of GML. These data will be useful in developing therapeutic tools to treat anthrax disease, whether in animals or humans. These results also suggest that mechanisms of virulence regulation exist independent ofatxA.